Tuesday, 6 October 2026Updated 14m ago
← Market pulse
Expansion▲ Bullish for Lupin

Lupin launches triple-combination COPD inhaler in India after DCGI approval

4 sources · first seen 11:20 6 Oct · updated 13:25 6 Oct

The brief

Written from 4 reports · check the source before you trade
  • Formoflo-G MDI combines three established therapies in a twice-daily inhaler
  • The inhaler targets India's large COPD patient pool
  • The launch adds a product opportunity for Lupin in India's respiratory medicines market

Tags on this story

Pick a tag to see all its stories
Lupin₹2,011.00 · 1 todayPharma and healthcare21 todayUSFDA2 today

Read the reports

4 reports · earliest 11:20
Business StandardLupin launches fixed-dose triple-combination inhaler for COPD in India11:20MoneycontrolLupin launches new COPD inhaler in India after DCGI nod; combines three medicines in one13:15Economic TimesLupin launches fixed-dose triple combination inhaler for COPD in India13:23Business LineLupin launches fixed-dose triple combination inhaler for COPD in India13:25